Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_assertion type Assertion NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_head.
- NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_assertion wasGeneratedBy ECO_0000203 NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_provenance.
- NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_assertion wasDerivedFrom befree-20140225 NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_provenance.
- NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_assertion SIO_000772 12646934 NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_provenance.
- NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_assertion evidence source_evidence_literature NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_provenance.
- NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_assertion description "[Imatinib mesylate, an Abl-specific kinase inhibitor, produces sustained complete hematologic responses (CHR) and major cytogenetic responses (MCR) in chronic myeloid leukemia (CML) patients, but long-term outcomes in these patients are not yet known.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846528.RAE4o3UCmSi68wpeHWNy8RTlDpQt7epZSH9uKXJa8S8qU130_provenance.